Twice Daily PPI Induces Higher Remission Rate in Eosinophilic Esophagitis Than Once Daily Regimen Regardless of Total Daily Dose

Devan Patel, MD

&

A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

Megan White, MD

Please Contact Beth Buschard-Steiger (bbuscha@wustl.edu) for Zoom Details